B of A Securities Downgrades Acadia Healthcare (ACHC)
Fintel reports that on September 10, 2025, B of A Securities downgraded their outlook for Acadia Healthcare (NasdaqGS:ACHC) from Buy to Neutral.
Analyst Price Forecast Suggests 47.37% Upside
As of September 2, 2025, the average one-year price target for Acadia Healthcare is $31.04/share. The forecasts range from a low of $20.20 to a high of $57.75. The average price target represents an increase of 47.37% from its latest reported closing price of $21.06 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Acadia Healthcare is 3,251MM, an increase of 0.66%. The projected annual non-GAAP EPS is 4.00.
What is the Fund Sentiment?
There are 685 funds or institutions reporting positions in Acadia Healthcare.
This is an decrease of 16 owner(s) or 2.28% in the last quarter.
Average portfolio weight of all funds dedicated to ACHC is 0.17%, an increase of 19.17%.
Total shares owned by institutions increased in the last three months by 3.89% to 121,727K shares.
The put/call ratio of ACHC is 0.64, indicating a
bullish outlook.
What are Other Shareholders Doing?

Wellington Management Group Llp holds 8,430K shares representing 9.13% ownership of the company. In its prior filing, the firm reported owning 10,873K shares , representing a decrease of 28.97%. The firm decreased its portfolio allocation in ACHC by 92.32% over the last quarter.
VGHCX - Vanguard Health Care Fund Investor Shares holds 5,568K shares representing 6.03% ownership of the company. No change in the last quarter.
Sachem Head Capital Management holds 4,215K shares representing 4.56% ownership of the company. In its prior filing, the firm reported owning 3,635K shares , representing an increase of 13.76%. The firm decreased its portfolio allocation in ACHC by 32.43% over the last quarter.
UBS Group holds 3,986K shares representing 4.32% ownership of the company. In its prior filing, the firm reported owning 1,170K shares , representing an increase of 70.65%. The firm decreased its portfolio allocation in ACHC by 55.80% over the last quarter.
Abrams Bison Investments holds 3,580K shares representing 3.88% ownership of the company. In its prior filing, the firm reported owning 1,820K shares , representing an increase of 49.16%. The firm increased its portfolio allocation in ACHC by 26.06% over the last quarter.